BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 2, 2006
View Archived Issues
TMC-114 plus ritonavir safe in HIV-hepatitis coinfection
Read More
R-1626 shows promise in hepatitis C
Read More
AEE-788 investigated in hepatocellular carcinoma
Read More
Pentoxifylline assessed in clinical trials in liver diseases
Read More
Platrol, a safe sustained release antiplatelet drug
Read More
CTT Cancer Targeting Technologies and Karyon to merge
Read More
Crofelemer studied for D-IBS in new phase IIb trial
Read More
Stelic discovers new treatment approach for acute liver failure
Read More
Acenta and NCI collaborate on novel Akt inhibitors for cancer
Read More
Adherex and SIOPEL sign in support of phase III oroprotectant study of STS
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
New therapeutic agents for gastrointestinal disorders disclosed in recent patents
Read More
Novel agents for fibrotic disorders patented
Read More
Novel CYP2A inhibitors for smoking cessation patented by InflaZyme
Read More
Novel cannabinoid agonists reported by Adolor
Read More
Satori Pharmaceuticals' SPI-014 exhibits Abeta42-lowering activity in vitro and in vivo
Read More
Secretin studied for utility in functional MRI of the pancreas
Read More
Ribose shows potential in CHF patients
Read More
Genasense: NDA review extended in CLL, pivotal enrollment completed in AML
Read More
MB-07811 studied in phase I for management of hyperlipidemia
Read More
NG2-73 begins phase II study in chronic insomnia patients
Read More
BIW-8405 begins phase I trial for asthma
Read More
Albany Molecular Research advances oncology candidate towards IND filing
Read More
Merck & Co. to acquire Sirna Therapeutics
Read More
RP-101 cleared to begin phase II study in pancreatic cancer
Read More
Advexin to be filed under EMEA Exceptional Circumstances rules
Read More
Tesofensine cleared for phase I/II metabolic study
Read More
Phase II findings for U-101 in chronic pelvic pain of bladder origin
Read More
Emerging natural products for the treatment of neurological disorders: Part II
Read More
Emisphere's oral insulin shows efficacy in type 2 diabetes patients
Read More
FDA approval for Polyphenon E Ointment
Read More
Approvable letter for Zenvia
Read More